Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2111685 | Cancer Genetics and Cytogenetics | 2007 | 4 Pages |
Abstract
The t(2;11)(q37;q23) is a rare recurrent cytogenetic abnormality associated with de novo and therapy-related acute myeloid leukemia, resulting in a MLL-SEPT2 fusion gene. We report on a case of therapy-related acute myeloid leukemia M2 showing a t(2;11)(q37;q23) and resulting in a new subtype of a MLL-SEPT2 chimeric transcript. The literature on this translocation is reviewed.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ellen van Binsbergen, Okke de Weerdt, Arjan Buijs,